Altus Pharmaceuticals Inc.
Healthcare · Biological Products, (No Diagnostic Substances) · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Material events
SEC Form 8-K · most recent- Bankruptcy or receivershipNov 12, 2009
- Director / officer changeNov 4, 2009
- Completed an acquisition or dispositionOct 8, 2009
- Delisting / listing-standard noticeSep 18, 2009
- Costs from exit or disposal · Material impairmentSep 14, 2009
- Costs from exit or disposalSep 9, 2009
- Delisting / listing-standard noticeAug 21, 2009
- Other material eventAug 17, 2009
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- REVOKEDSep 19, 2013
- SC 13G/ASCHEDULE 13G/AFeb 10, 2010
- CT ORDERJan 20, 2010
- CT ORDERJan 20, 2010
- 25-NSEDec 15, 2009
- 8-KLIVE FILINGNov 12, 2009
- 8-KLIVE FILINGNov 4, 2009
- 8-KLIVE FILINGOct 8, 2009
- 8-KLIVE FILINGSep 18, 2009
- 4PRIMARY DOCUMENTSep 16, 2009
- 4PRIMARY DOCUMENTSep 16, 2009
- 8-KLIVE FILINGSep 14, 2009
- 8-KLIVE FILINGSep 9, 2009
- 8-KLIVE FILINGAug 21, 2009
- 8-KLIVE FILINGAug 17, 2009
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.